Joseph Loscalzo
Known title: DirectorCIK: 0001276128
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
CYPH in Spotlight as Smaller Health Care Names Outperform. Recent coverage noted that smaller health‑care names outperformed larger peers, and CYPH is among those that could benefit from the sector’s momentum. The same report highlighted significant whale activity in health‑care stocks, suggesting growing institutional interest. These developments may affect CYPH’s trading dynamics. No specific price guidance is provided.
Transaction History
| IONS | ▲ Buy | Option Exercise | 16,000 | $1.0M | 5/4/2026 | View on chart |
| IONS | ▲ Buy | Option Exercise | 10,968 | $417K | 5/4/2026 | View on chart |
| IONS | ▲ Buy | Option Exercise | 12,000 | $481K | 5/4/2026 | View on chart |
| IONS | ▲ Buy | Option Exercise | 10,321 | $424K | 5/4/2026 | View on chart |
| IONS | ▲ Buy | Option Exercise | 16,000 | $686K | 5/4/2026 | View on chart |
| IONS | ▲ Buy | Option Exercise | 12,000 | $722K | 5/4/2026 | View on chart |
| IONS | ▼ Sell | Open Market | 59,508 | $4.5M | 5/4/2026 | View on chart |
| IONS | ▼ Sell | Open Market | 17,781 | $1.3M | 5/4/2026 | View on chart |
| CYPH | ▲ Buy | Option Exercise | 74,700 | — | 3/13/2026 | View on chart |
| CYPH | ▲ Buy | Option Exercise | 94,050 | — | 3/13/2026 | View on chart |
| IONS | ▲ Buy | Option Exercise | 200 | $8K | 3/4/2026 | View on chart |
| IONS | ▼ Sell | Open Market | 200 | $16K | 3/4/2026 | View on chart |
| IONS | ▲ Buy | Option Exercise | 832 | $32K | 3/3/2026 | View on chart |
| IONS | ▼ Sell | Open Market | 832 | $67K | 3/3/2026 | View on chart |
| IONS | ▲ Buy | Option Exercise | 16,000 | $836K | 10/31/2025 | View on chart |
| IONS | ▼ Sell | Open Market | 16,000 | $1.2M | 10/31/2025 | View on chart |
| IONS | ▲ Buy | Option Exercise | 16,000 | $391K | 9/3/2025 | View on chart |
| IONS | ▼ Sell | Open Market | 16,000 | $962K | 9/3/2025 | View on chart |
| IONS | ▲ Buy | Option Exercise | 4,079 | $0 | 7/15/2025 | View on chart |
| IONS | ▼ Sell | Open Market | 13,508 | $511K | 11/12/2024 | View on chart |
| IONS | ▲ Buy | Option Exercise | 4,677 | $0 | 7/15/2024 | View on chart |
| IONS | ▲ Buy | Option Exercise | 1,777 | $0 | 7/17/2023 | View on chart |
| IONS | ▲ Buy | Option Exercise | 5,333 | $0 | 7/17/2023 | View on chart |
| IONS | ▲ Buy | Option Exercise | 2,665 | $0 | 7/15/2022 | View on chart |
| IONS | ▲ Buy | Option Exercise | 5,333 | $0 | 7/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Cathie Wood adds to Ionis position amid RNA sector interest
Cathie Wood has increased her holdings in Ionis Pharmaceuticals as part of a broader bet on two stocks. This move highlights continued investor interest in RNA therapeutics, a sector currently drawing attention for its innovation potential. While the stock is trading near its 52-week low, the average analyst target remains significantly higher than the current price.
Cathie Wood adds to Ionis position amid RNA sector interest. Cathie Wood has increased her holdings in Ionis Pharmaceuticals as part of a broader bet on two stocks. This move highlights continued investor interest in RNA therapeutics, a sector currently drawing attention for its innovation potential. While the stock is trading near its 52-week low, the average analyst target remains significantly higher than the current price.